Insulin Resistance, Metabolic Syndrome and Micro-RNA-122 Serum Level in Patients with Cerebral Venous Sinus Thrombosis: a Case-control Study

Overview

Journal Thromb J

Publisher Biomed Central

Date 2024 Nov 20

PMID 39563387

Authors

Mohammed I Oraby

Manar M Haddad

Mona Nasser

Mona Hussein

Affiliations

Soon will be listed here.

Abstract

Background: The relationship between venous thromboembolism and both insulin resistance and metabolic syndrome is still a matter of debate. The objective of this work was to investigate the possible association between cerebral venous sinus thrombosis (CVST) and both insulin resistance and metabolic syndrome. We aimed also to assess micro-RNA-122 serum levels in patients with CVST in comparison to controls.

Methods: This case-control study was conducted on patients having a clinical and neuroimaging diagnosis of acute CVST (within 1 week from the onset). Patients with inconclusive brain imaging, those with a history of malignancy, diabetic patients, and patients on drugs known to affect the insulin sensitivity or lipid profile were excluded from the study. Metabolic syndrome in the included cases and controls was evaluated by measuring waist circumference and blood pressure in addition to assessment of Triglycerides, HDL, and fasting blood sugar. The state of insulin resistance was established if the Homeostasis model assessment-insulin resistance (HOMA-IR) value > 2.5. Serum micro-RNA-122 serum level was measured for both patients and controls.

Results: In the present study, 36 cases diagnosed as having CVST and 34 age & sex matched controls were included. There were statistically significant differences between patients with CVST and controls regarding BMI, waist circumference, TG, fasting glucose, fasting insulin & HOMA- IR (P-value = 0.002, 0.001, 0.004, 0.003, 0.021, 0.008 respectively). There was no statistically significant difference between patients with CVST and controls regarding micro-RNA-122 serum level (P-value = 0.376), whereas CVST patients with insulin resistance had a significantly higher micro-RNA-122 serum level in comparison to those without (P-value < 0.001). Patients with CVST had a significantly higher frequency of both metabolic syndrome and insulin resistance in comparison to controls (P-value = 0.008, 0.002 respectively).

Conclusion: There is a significant association between CVST and both insulin resistance and metabolic syndrome.

References

Abuduhalike R, Yadav U, Sun J, Mahemuti A . Idiopathic Venous Thromboembolism and Metabolic Syndrome: A Meta-analysis. J Coll Physicians Surg Pak. 2022; 32(7):909-914. DOI: 10.29271/jcpsp.2022.07.909. View

Morelli V, Lijfering W, Bos M, Rosendaal F, Cannegieter S . Lipid levels and risk of venous thrombosis: results from the MEGA-study. Eur J Epidemiol. 2017; 32(8):669-681. PMC: 5591362. DOI: 10.1007/s10654-017-0251-1. View

Yamada H, Suzuki K, Ichino N, Ando Y, Sawada A, Osakabe K . Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta. 2013; 424:99-103. DOI: 10.1016/j.cca.2013.05.021. View

Raynaud E, Perez-Martin A, Brun J, Fedou C, Mercier J . Relationships between fibrinogen and insulin resistance. Atherosclerosis. 2000; 150(2):365-70. DOI: 10.1016/s0021-9150(99)00373-1. View

Meigs J, Mittleman M, Nathan D, Tofler G, Singer D, Lipinska I . Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA. 2000; 283(2):221-8. DOI: 10.1001/jama.283.2.221. View

Trost S, Pratley R, Sobel B . Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes. Curr Diab Rep. 2006; 6(1):47-54. DOI: 10.1007/s11892-006-0052-5. View

Yudkin J, Stehouwer C, Emeis J, Coppack S . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999; 19(4):972-8. DOI: 10.1161/01.atv.19.4.972. View

Scott C, Kardon R, Lee A, Frisen L, Wall M . Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010; 128(6):705-11. DOI: 10.1001/archophthalmol.2010.94. View

Esau C, Davis S, Murray S, Yu X, Pandey S, Pear M . miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006; 3(2):87-98. DOI: 10.1016/j.cmet.2006.01.005. View

10.

Alessi M, Juhan-Vague I . Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost. 2008; 99(6):995-1000. DOI: 10.1160/TH07-11-0682. View

11.

Alessi M, Juhan-Vague I . PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol. 2006; 26(10):2200-7. DOI: 10.1161/01.ATV.0000242905.41404.68. View

12.

Lowe G, Rumley A, Woodward M, Reid E, Rumley J . Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variables. Thromb Haemost. 1999; 81(6):918-24. View

13.

Woodward M, Lowe G, Rumley A, Tunstall-Pedoe H, Philippou H, Lane D . Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 1997; 97(4):785-97. DOI: 10.1046/j.1365-2141.1997.1232935.x. View

14.

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

15.

Delluc A, de Moreuil C, Kerspern H, Le Moigne E, Mottier D, Tromeur C . Body mass index, a major confounder to insulin resistance association with unprovoked venous thromboembolism. Results from the EDITH case-control study. Thromb Haemost. 2013; 110(3):593-7. DOI: 10.1160/TH13-01-0048. View

16.

Garcia Raso A, Ene G, Miranda C, Vidal R, Mata R, Llamas Sillero M . [Association between venous thrombosis and dyslipidemia]. Med Clin (Barc). 2013; 143(1):1-5. DOI: 10.1016/j.medcli.2013.07.024. View

17.

Dentali F, Romualdi E, Ageno W . The metabolic syndrome and the risk of thrombosis. Haematologica. 2007; 92(3):297-9. DOI: 10.3324/haematol.11243. View

18.

Doggen C, Smith N, Lemaitre R, Heckbert S, Rosendaal F, Psaty B . Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol. 2004; 24(10):1970-5. DOI: 10.1161/01.ATV.0000143134.87051.46. View

19.

Yudkin J . Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?. Diabetes Care. 1999; 22 Suppl 3:C25-30. View

20.

Saposnik G, Barinagarrementeria F, Brown Jr R, Bushnell C, Cucchiara B, Cushman M . Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42(4):1158-92. DOI: 10.1161/STR.0b013e31820a8364. View